文献
J-GLOBAL ID:202202217127112611
整理番号:22A0704096
第一選択ゲフィチニブの進行後の上皮増殖因子受容体変異陽性進行非小細胞肺癌の高齢患者の生存解析【JST・京大機械翻訳】
Survival analysis for older patients with epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after progression of first-line gefitinib
著者 (5件):
Nie Xin
(Department of Medical Oncology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China)
,
Zhang Ping
(Department of Medical Oncology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China)
,
Cheng Gang
(Department of Medical Oncology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China)
,
Wu Xiao-Nan
(Department of Medical Oncology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China)
,
Li Lin
(Department of Medical Oncology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China)
資料名:
Asia-Pacific Journal of Clinical Oncology
(Asia-Pacific Journal of Clinical Oncology)
巻:
18
号:
1
ページ:
150-155
発行年:
2022年
JST資料番号:
W2498A
ISSN:
1743-7555
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)